BM2101 Ceftiofur (incl. BSA conjugate) antibody

See related secondary antibodies

Search for all "Ceftiofur"

1 ml / €1,300.00

Quick Overview

Mouse anti Ceftiofur CH-2034


Product Description for Ceftiofur

Mouse anti Ceftiofur CH-2034.
Properties: (incl. BSA conjugate)
Presentation: Ascites
Product is tested for Enzyme Immunoassay, Radioimmunoassay.

Properties for Ceftiofur

Product Category Primary Antibodies
Quantity 1 ml
Presentation Ascites
Applications E, R
Clonality Monoclonal
Clone CH-2034
Host Mouse
Isotype IgG1
Shipping to Worldwide
PDF datasheet View Datasheet
Manufacturer Acris Antibodies GmbH
Material safety datasheet MSDS for Monoclonal Antibodies (de)

Datasheet Extract

Property incl. BSA conjugate
Application ELISA (suggested dilution: 1:1,500). Sensitivity is approximately 100 pg/ml when used with included conjugated control.
Background Ceftiofur, a semisynthetic cephalosporin, is a broad-spectrum antibiotic against both Gram-positive and Gram-negative bacteria including beta-lactamase-producing bacterial strains and anaerobes. Its antibacterial activity results from the inhibition of mucopeptide synthesis in the cell wall in a similar fashion to other cephalosporins. Ceftiofur is used in the treatment of respiratory infections in cattle and pigs.
Protocols Includes BSA Conjugated Control
Format:Purified, Liquid
Buffer:PBS, containing 0.05 % Sodium azide
Application: A standard dilution of 1:1,500 is suggested in ELISA
Storage Store the antibody undiluted at -20 °C. Avoid repeated freezing and thawing. Should this product contain a precipitate we recommend microcentrifugation before use. Shelf life: one year from despatch.
Buffer System:
PBS as buffer, containing 0.05 % Sodium azide as preservative.
Liquid diluted ascites
This antibody reacts with Ceftiofur. Does not react with desfuroylceftiofur (ceftiofur with cleaved thioester), other beta-lactam antibiotics such as cephalosporin C, cephapirin, or penicillin, other classes of antibiotics, or milk and serum proteins.

Accessory Products

  • LinkedIn